08/24/2026
What happens to your heart risk after you stop taking a GLP-1 medication? Dr. Andreas Kalogeropoulos at Stony Brook Medicine received American Heart Association funding to find out using real-world data from 100M+ patients🫀
Learn more about the grant titled “Understanding Rebound Cardiovascular Risk After GLP-1 RA Discontinuation Using Target Trial Emulation" here: https://renaissance.stonybrookmedicine.edu/medicine/news_blog/kalogeropoulos-aha-grant-GLP1